A combination of β-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease

Jacob A. Torres, Nickolas J. Holznecht, David A. Asplund, Tselmeg Amarlkhagva, Bradley C. Kroes, Juliette R. Rebello, Shagun Agrawal, Thomas Weimbs

American Journal of Physiology-Renal Physiology · 2023 · 15 citations · 52 references

DOIFull text

Open access

Concepts

Abstract

Combining β-hydroxybutyrate (BHB) and citrate effectively slows and prevents cyst formation and expansion in young Cy/+ rats using less BHB and citrate than when used alone, demonstrating synergy. In adult rats, the combination causes a partial reversal of existing disease, reducing cyst number and cystic area, preserving glomerular health, and decreasing markers of kidney injury. Our results suggest a safe and feasible strategy for supporting kidney health in polycystic kidney disease (PKD) using a combination of BHB and citrate.

References

52